Empower Clinics Inc.

Equities

EPW

CA29246V2030

Healthcare Facilities & Services

Delayed Canadian Securities Exchange Other stock markets 01:48:49 2023-08-14 pm EDT			5-day change	1st Jan Change
0.04 ^CAD	-20.00%		+33.33%	-.--%

Apr. 02	Empower Clinics Inc. announced that it expects to receive CAD 0.976 million in funding	CI
2023	Empower Clinics Inc.'S Subsidiary EPW Curesearch LLC Signs New Agreements for Additional Pharmaceutical Research and Clinical Trials Medical Doctors with an Established Pain Management Practice and Includes Two Experienced Principal Investigators	CI

Empower Clinics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

November 01, 2022

Empower Clinics Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 1.55 million compared to USD 0.861826 million a year ago. Net income was USD 2.17 million compared to net loss of USD 0.57932 million a year ago. Basic earnings per share from continuing operations was USD 0.05. Basic earnings per share was USD 0.05.
For the six months, sales was USD 2.66 million compared to USD 2.82 million a year ago. Net income was USD 0.000845 million compared to net loss of USD 25.79 million a year ago.

Latest news about Empower Clinics Inc.

Empower Clinics Inc. announced that it expects to receive CAD 0.976 million in funding	Apr. 01	CI
Empower Clinics Inc.'S Subsidiary EPW Curesearch LLC Signs New Agreements for Additional Pharmaceutical Research and Clinical Trials Medical Doctors with an Established Pain Management Practice and Includes Two Experienced Principal Investigators	23-08-16	CI
Empower Clinics Inc. agreed to Spin-Off Healthcare artificial intelligence (AI) technology business.	23-07-31	CI
Empower Clinics Plans Private Placement	23-06-23	MT
Empower Clinics Inc. announced that it expects to receive CAD 0.30565 million in funding	23-06-22	CI
Empower Clinics Brief: Edging Up After Announcing Plan to Consolidate Its Issued and Outstanding Common Shares On Basis of One Post-consolidation Share For Every Five	23-06-19	MT
Empower Clinics Inc.'s Subsidiary EPW Curesearch LLC Signs Research Services Agreement with A Principal Investigator	23-05-03	CI
Empower Clinics SignsTwo Additional Principal Investigators at First Site in Dallas, Texas	23-04-25	MT
Empower Clinics Inc. Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi	23-04-20	CI
Empower Clinics Inc. Announces Signing of First Principal Investigator	23-04-17	CI
Empower Clinics Announcing Exploration of Strategic Alternatives	23-03-21	MT
Empower Clinics Brief: Announcing Exploration of Strategic Alternatives	23-03-21	MT
Empower Clinics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
Empower Clinics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-28	CI
Fobi Signs New PulseIR Deal with Empower Clinics	23-02-02	MT
Fobi Signs New PulseIR Deal with Empower Clinics	23-02-02	CI
Empower Clinics Plans to Raise up to $5 Million from Units Offering	23-01-23	MT
Empower Clinics Brief: Edging Down As Moves To Consolidate Three of its The Medi-Collective Medical Clinics with Resources to be Focused into Flagship Etobicoke integrated medical clinic	23-01-11	MT
Empower Clinics Brief: MediSure Laboratory to offer clinical study services for client expansion to US market	23-01-10	MT
Empower Clinics Brief: Edging Up As Subsidiary Wins Laboratory Services Agreement with European Medical Products Manufacturer	23-01-10	MT
Empower Clinics Subsidiary Wins Laboratory Services Agreement with European Medical Products Manufacturer	23-01-10	CI
Empower Clinics Inc. Announces Change of Year End	22-12-23	CI
Empower Clinics Inc. Signs Partnership Agreement with Leading European Medical Diagnostics and Device Company	22-12-19	CI
Empower Clinics Inc. announced that it has received CAD 0.8425 million in funding	22-12-12	CI
Empower Clinics Announces Partnership with Specialty Networks of North America to Serve Underserved Communities Across U.S	22-12-07	CI

Chart Empower Clinics Inc.

Duration

Period

More charts

Company Profile

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.

Sector

Healthcare Facilities & Services

Calendar

2024-06-03 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
EMPOWER CLINICS INC.	-.--%	3.04M
HCA HEALTHCARE, INC.	+18.61%	84.52B
CVS HEALTH CORPORATION	-27.22%	72.21B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.74B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.14%	17.97B
FRESENIUS SE & CO. KGAA	-0.57%	17.46B
QUEST DIAGNOSTICS INCORPORATED	+3.25%	15.82B
REDE D'OR SÃO LUIZ S.A.	+5.84%	13.55B
FRESENIUS MEDICAL CARE AG	+5.66%	13.31B
TENET HEALTHCARE CORPORATION	+70.21%	12.5B

Other Healthcare Facilities & Services